To evaluate the efficacy and safety of zanolimumab in Mycosis Fungoides and sezary syndrome
Showing 1 - 25 of >10,000
Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoides/Sezary Syndrome Trial in Saint Louis (Tulmimetostat)
Not yet recruiting
- Mycosis Fungoides
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 13, 2023
Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon
Active, not recruiting
- Metastatic Myxoid Liposarcoma
- +15 more
- Interferon Gamma-1b
- +2 more
-
Palo Alto, California
- +6 more
Aug 2, 2022
Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15
Completed
- Adult T-Cell Lymphoma/Leukemia
- +2 more
- Recombinant human Interleukin-15 (rhIL-15)
- Mogamulizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 9, 2022
Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States
Recruiting
- Mycosis Fungoides
- +11 more
- Biospecimen Collection
- +5 more
-
Duarte, California
- +12 more
Jan 7, 2023
Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome Trial in United States (brentuximab vedotin)
Recruiting
- Mycosis Fungoides
- +2 more
- brentuximab vedotin
-
Stanford, California
- +7 more
Nov 3, 2022
Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)
Recruiting
- Sezary Syndrome
- Mycosis Fungoides
- Mogamulizumab
- LD TSEBT
-
Stanford, CaliforniaStanford Cancer Center
Oct 19, 2022
Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IV
Recruiting
- Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
- +2 more
- Duvelisib
- +2 more
-
Phoenix, Arizona
- +11 more
Aug 6, 2022
Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,
Recruiting
- Mycosis Fungoides
- +2 more
- Extracorporeal Photopheresis
- +2 more
-
Atlanta, GeorgiaEmory University Hospital
Jun 15, 2022
Mycosis Fungoides, Sezary Syndrome, Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Trial in Jacksonville (Pembrolizumab)
Recruiting
- Mycosis Fungoides
- +12 more
- Pembrolizumab
-
Jacksonville, FloridaMayo Clinic in Florida
Mar 22, 2022
Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)
Active, not recruiting
- Lymphoma, T-Cell, Cutaneous
- Mycosis Fungoides/Sezary Syndrome
-
Madrid, Spain
- +1 more
Jul 1, 2022
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Recruiting
- Mycosis Fungoides
- Non-Hodgkin's Lymphoma
-
Duarte, California
- +12 more
Jun 17, 2022
Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,
Active, not recruiting
- Folliculotropic Mycosis Fungoides
- +7 more
- Extracorporeal Photopheresis
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
CTCL, Mycosis Fungoides, Sezary Syndrome Trial in New York (Ritlecitinib)
Recruiting
- CTCL
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 18, 2023
Mapping Emotional Dynamics During Corticosteroid Treatment
Recruiting
- Emotions
- Corticosteroids
- Short daily questionnaire
-
Leiden, Zuid-Holland, NetherlandsLUMC
Aug 30, 2022
Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Worldwide (resminostat, Placebo)
Active, not recruiting
- Mycosis Fungoides
- +2 more
- resminostat
- Placebo
-
Graz, Austria
- +53 more
Dec 12, 2022
Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)
Not yet recruiting
- Cutaneous T Cell Lymphoma
- Fungoides Mycosis Sezary Syndrome
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Jul 13, 2023
Patients With Mycosis Fungoides and Sézary Syndrome.
Recruiting
- Mycosis Fungoides
- Sezary Syndrome
- Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.
-
Lund, SwedenLund University Hospital
May 21, 2021
Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,
Terminated
- Mycosis Fungoides
- +2 more
- Naloxone Hydrochloride Lotion, 0.5%
- Placebo Lotion
-
Little Rock, Arkansas
- +15 more
Oct 26, 2022
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United
Recruiting
- Folliculotropic Mycosis Fungoides
- +7 more
- Durvalumab
- +2 more
-
Duarte, California
- +3 more
Jan 12, 2023
T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)
Not yet recruiting
- T-Cell Non-Hodgkin Lymphoma
- +14 more
- WU-CART-007
-
Saint Louis, MissouriWashington University School of Medicine
Jan 17, 2023
Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Zürich (Methoxsalen, THERAKOS CELLEX Photopheresis
Withdrawn
- Lymphoma, T-Cell, Cutaneous
- Mycosis Fungoides/Sezary Syndrome
- Methoxsalen
- THERAKOS CELLEX Photopheresis System
-
Zürich, SwitzerlandUniversitaetsSpital Zurich - Division of Dermatology
Aug 31, 2021
Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome Trial in Leeds ([14C]-resminostat)
Completed
- Cutaneous T Cell Lymphoma
- +2 more
-
Leeds, United KingdomCovance Clinical research Unit Ltd.
Feb 3, 2022
Poteligeo in Adult Patients With MF and SS (PROSPER)
Not yet recruiting
- Mycosis Fungoides and Sézary Syndrome
-
Saint Louis, Missouri
- +15 more
Jul 8, 2022
Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
Not yet recruiting
- Cutaneous T Cell Lymphoma
- +2 more
-
Ancona, Italy
- +19 more
Nov 2, 2023